Drug maker Teva agrees to $4.3 billion national settlement over opioid lawsuits - MarketWatch
Here's Why Teva Shares are Trending Higher Today - TipRanks.com
Teva Bonds: 8.8% Yield To Maturity Understates Upside (NYSE:TEVA) | Seeking Alpha
Israel's TEVA, PERI Tank on Q4 Earnings; IZRL in Focus - TipRanks.com
TEVA PHARMACEUTICAL INDUSTRIES LIMITED : TEVA Stock Price | US8816242098 | MarketScreener
Teva Bonds: 8.8% Yield To Maturity Understates Upside | Nasdaq
Teva Pharmaceutical Industries Ltd's (ADR) (TEVA) GmbH and Alder BioPharmaceuticals Form Global License Agreement
Teva Stock: Teva Guides To Its First Year Of Growth Since 2017, But There's A Caveat | Investor's Business Daily
Teva Reports First Quarter 2021 Financial Results | Business Wire
Teva Pharmaceuticals Agrees To $85 Million Settlement With Oklahoma In Opioid Case | KPBS Public Media
Teva to pay up to $4.2 billion in U.S. to settle opioid claims | MarketScreener
Teva Reports Second Quarter 2021 Financial Results | Business Wire
Teva Pharma Trends Lower Ahead Of A Key Shareholder Meeting This Week (NYSE: TEVA) | Seeking Alpha
TEVA Earnings Date 2023 | Teva Pharmaceutical Industries Earnings Forecast
Do Analysts Expect Teva Pharmaceutical Industries Ltd (TEVA) Stock to Rise After It Has Gained 10.21% in a Month?
Infographic: Teva Pharmaceuticals (TEVA) Q1 2021 earnings results | AlphaStreet
Teva: 'Celltrion deal will double biosimilar sales to $600m'
Teva Pharmaceuticals reports earnings on Wednesday. Here's what to expect - MarketWatch
New York Attorney General Letitia James secures $523 million from Teva Pharmaceuticals for role in opioid crisis | State | wktv.com
TEVA PHARMACEUTICAL INDUSTRIES LIMITED : TEV Stock Price | US8816242098 | MarketScreener
DEF 14A
Definitive Proxy Statement
Why Teva Pharmaceutical Is Substantially More (NYSE:TEVA) | Seeking Alpha
Teva Pharmaceutical Industries Stock Gives Every Indication Of Being Modestly Undervalued
Teva Faces Rocky Path to Recovery After Debt | Fortune
TEVA PHARMACEUTICAL INDUSTRIES LIMITED : TEVA Stock Price | IL0006290147 | MarketScreener
DEF 14A
Teva Prepared to Fight Charges in Generics Probe If Talks Fail - Bloomberg
